Female estrogen-related factors and incidence of basal cell carcinoma in a nationwide us cohort

Journal of Clinical Oncology

Volumn 33, Issue 34, 2015, Pages 4058-4065

  Cahoon, Elizabeth K ^a   Kitahara, Cari M ^a   Ntowe, Estelle ^a   Bowen, Emily M ^a   Doody, Michele M ^a   Alexander, Bruce H ^b   Lee, Terrence ^a   Little, Mark P ^a   Linet, Martha S ^a   Freedman, D Michal ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIETHYLSTILBESTROL; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MENOPAUSE; PARITY; PRIORITY JOURNAL; SUN EXPOSURE; ULTRAVIOLET RADIATION; ADOLESCENT; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, BASAL CELL; CHILD; ESTROGEN THERAPY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCTIVE HISTORY; RISK FACTOR; SKIN NEOPLASMS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CARCINOMA, BASAL CELL; CHILD; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UNITED STATES; YOUNG ADULT;

EID: 84951750213     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.62.0625     Document Type: Article

References (39)

1. Rogers HW, Weinstock MA, Harris AR, et al: Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-287, 2010
2. Rubin AI, Chen EH, Ratner D: Basal-cell carcinoma. N Engl J Med 353:2262-2269, 2005
3. Moore DE: Drug-induced cutaneous photosensitivity: Incidence, mechanism, prevention and management. Drug Saf 25:345-372, 2002
4. Stern RS: Photocarcinogenicity of drugs. Toxicol Lett 102-103:389-392, 1998
5. Cooper SM, George S: Photosensitivity reaction associated with use of the combined oral contraceptive. Br J Dermatol 144:641-642, 2001
6. Erickson LR, Peterka ES: Sunlight sensitivity from oral contraceptives. JAMA 203:980-981, 1968
7. Thornton MJ: The biological actions of estrogens on skin. Exp Dermatol 11:487-502, 2002
8. Westerholm B: Clinical toxicology of estrogens. Pharmacol Ther 10:337-349, 1980
9. O'Gorman SM, Murphy GM: Photosensitizing medications and photocarcinogenesis. Photodermatol Photoimmunol Photomed 30:8-14, 2014
10. Daniels K, Mosher WD: Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Report 62:1-15, 2013
11. Lacey JV Jr.: The WHI ten year's later: An epidemiologist's view. J Steroid Biochem Mol Biol 142:12-15, 2014
12. Birkhäuser MH, Reinecke I: Current trends in hormone replacement therapy: Perceptions and usage. Climacteric 11:192-200, 2008
13. Tang JY, Spaunhurst KM, Chlebowski RT, et al: Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: Women's health initiative randomized trials. J Natl Cancer Inst 103:1469-1475, 2011
14. Birch-Johansen F, Jensen A, Olesen AB, et al: Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes Control 23:379-388, 2012
15. Vessey MP, Painter R, Powell J: Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index: Findings in a large cohort study. Br J Dermatol 143:815-820, 2000
16. Högnäs E, Kauppila A, Pukkala E, et al: Cancer risk in women with 10 or more deliveries. Obstet Gynecol 123:811-816, 2014
17. Boice JD Jr., Mandel JS, Doody MM, et al: A health survey of radiologic technologists. Cancer 69:586-598, 1992
18. Doody MM, Mandel JS, Lubin JH, et al: Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control 9:67-75, 1998
19. Evashwick C, Rowe G, Diehr P, et al: Factors explaining the use of health care services by the elderly. Health Serv Res 19:357-382, 1984
20. Christian B, Chattopadhyay A, Kingman A, et al: Oral health care services utilisation in the adult US population: Medical Expenditure Panel Survey 2006. Community Dent Health 30:161-167, 2013
21. Skaar DD, O'Connor H: Dental service trends for older US adults, 1998-2006. Spec Care Dentist 32:42-48, 2012
22. Mosen DM, Pihlstrom DJ, Snyder JJ, et al: Assessing the association between receipt of dental care, diabetes control measures and health care utilization. J Am Dent Assoc 143:20-30, 2012
23. National Aeronautics and Space Administration: Total Ozone Mapping Spectrometer Data Product: Erythemal UV Exposure. Greenbelt, MD, Goddard Space Flight Center, 2004
24. Fioletov VE, McArthur LJ, Mathews TW, et al: On the relationship between erythemal and vitamin D action spectrum weighted ultraviolet radiation. J Photochem Photobiol B 95:9-16, 2009
25. Lean JL, Rottman GJ, Kyle HL, et al: Detection and parameterization of variations in solar mid-And near-ultraviolet radiation (200-400 nm). J Geophys Res-Atmos 102:29939-29956, 1997
26. Korn EL, Graubard BI, Midthune D: Time-toevent analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol 145:72-80, 1997
27. Miller KA, Langholz BM, Zadnick J, et al: Prevalence and predictors of recent skin examination in a population-based twin cohort. Cancer Epidemiol Biomarkers Prev 24:1190-1198, 2015
28. Coups EJ, Geller AC, Weinstock MA, et al: Prevalence and correlates of skin cancer screening among middle-Aged and older white adults in the United States. Am J Med 123:439-445, 2010
29. Saraiya M, Hall HI, Thompson T, et al: Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 39:308-314, 2004
30. Cahoon EK, Rajaraman P, Alexander BH, et al: Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study. Int J Cancer 130:2939-2948, 2012
31. Robinson SN, Zens MS, Perry AE, et al: Photosensitizing agents and the risk of non-melanoma skin cancer: A population-based case-control study. J Invest Dermatol 133:1950-1955, 2013
32. McDonald E, Freedman DM, Alexander BH, et al: Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort. Cancer Epidemiol Biomarkers Prev 23:1539-1545, 2014
33. Situm M, Buljan M, Bulat V, et al: The role of UV radiation in the development of basal cell carcinoma. Coll Antropol 32:167-170, 2008 (suppl 2)
34. Wu S, Han J, Laden F, et al: Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: A cohort study. Cancer Epidemiol Biomarkers Prev 23:1080-1089, 2014
35. O'Connor KA, Ferrell RJ, Brindle E, et al: Total and unopposed estrogen exposure across stages of the transition to menopause. Cancer Epidemiol Biomarkers Prev 18:828-836, 2009
36. Dawe RS, Ibbotson SH: Drug-induced photosensitivity. Dermatol Clin 32:363-368, 2014
37. Stegeman BH, de Bastos M, Rosendaal FR, et al: Different combined oral contraceptives and the risk of venous thrombosis: Systematic review and network meta-Analysis. BMJ 347:f5298, 2013
38. Nelson HD: Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review. JAMA 291:1610-1620, 2004
39. Ming ME, Levy RM, Hoffstad OJ, et al: Validity of patient self-reported history of skin cancer. Arch Dermatol 140:730-735, 2004